Jack, C. R. Jr et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 14, 535–562 (2018).
Article PubMed PubMed Central Google Scholar
Jellinger, K. A. Recent update on the heterogeneity of the Alzheimer’s disease spectrum. J. Neural Transm. 129, 1–24 (2022). A detailed review on the four different histopathological subtypes of Alzheimer disease, which also discusses the main clinical characteristics, the specific dementia phenotypes and the impact of co-pathologies.
Article CAS PubMed Google Scholar
Leng, F. & Edison, P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat. Rev. Neurol. 17, 157–172 (2021).
Dubois, B. et al. Preclinical Alzheimer’s disease: definition, natural history, and diagnostic criteria. Alzheimers Dement. 12, 292–323 (2016).
Article PubMed PubMed Central Google Scholar
Horvath, A., Szűcs, A., Barcs, G., Noebels, J. L. & Kamondi, A. Epileptic seizures in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 30, 186–192 (2016).
Vossel, K. A., Tartaglia, M. C., Nygaard, H. B., Zeman, A. Z. & Miller, B. L. Epileptic activity in Alzheimer’s disease: causes and clinical relevance. Lancet Neurol. 16, 311–322 (2017).
Article PubMed PubMed Central Google Scholar
Palop, J. J. & Mucke, L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat. Rev. Neurosci. 17, 777–792 (2016).
Article CAS PubMed PubMed Central Google Scholar
Romoli, M., Sen, A., Parnetti, L., Calabresi, P. & Costa, C. Amyloid-β, a potential link between epilepsy and cognitive decline. Nat. Rev. Neurol. 17, 469–485 (2021). This paper presents the most recent findings on the role of amyloid-β in the development of both cognitive decline and epilepsy in Alzheimer disease through shared pathomechanistic pathways.
Article CAS PubMed Google Scholar
Sen, A., Jette, N., Husain, M. & Sander, J. W. Epilepsy in older people. Lancet 395, 735–748 (2020).
Lee, S. K. Epilepsy in the elderly: treatment and consideration of comorbid diseases. J. Epilepsy Res. 9, 27–35 (2019).
Article PubMed PubMed Central Google Scholar
Johnson, E. L. et al. Dementia in late-onset epilepsy: the Atherosclerosis Risk in Communities study. Neurology 95, e3248–e3256 (2020).
Article CAS PubMed PubMed Central Google Scholar
Tang, T., Zhang, R. & Pan, X. Meta-analysis of the risk of dementia in elderly patients with late-onset epilepsy. Clin. Neurol. Neurosurg. 223, 107499 (2022).
Huang, L., Fu, C., Li, J. & Peng, S. Late-onset epilepsy and the risk of dementia: a systematic review and meta-analysis. Aging Clin. Exp. Res. 34, 1771–1779 (2022).
Cvetkovska, E. et al. Prevalence of various risk factors associated with new-onset epilepsy after the age of 50: a retrospective population-based study. Epileptic Disord. 24, 95–101 (2022).
Süße, M., Zank, M., von Podewils, V. & von Podewils, F. Autoimmune encephalitis in late-onset seizures: when to suspect and how to treat. Front. Neurol. 2, 633999 (2021).
Kawakami, O. et al. Incidence of dementia in patients with adult-onset epilepsy of unknown causes. J. Neurol. Sci. 395, 71–76 (2018).
Costa, C. et al. Alzheimer’s disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology. Neurobiol. Aging 73, 61–67 (2019).
Article CAS PubMed Google Scholar
Keret, O., Hoang, T. D., Xia, F., Rosen, H. J. & Yaffe, K. Association of late-onset unprovoked seizures of unknown etiology with the risk of developing dementia in older veterans. JAMA Neurol. 77, 710–715 (2020).
Nardi Cesarini, E. et al. Late-onset epilepsy with unknown etiology: a pilot study on neuropsychological profile, cerebrospinal fluid biomarkers, and quantitative EEG characteristics. Front. Neurol. 11, 199 (2020).
Article PubMed PubMed Central Google Scholar
Ophir, K., Ran, B., Felix, B. & Amir, G. Ten year cumulative incidence of dementia after late onset epilepsy of unknown etiology. J. Clin. Neurosci. 86, 247–251 (2021).
Reyes, A. et al. Diagnosing cognitive disorders in older adults with epilepsy. Epilepsia 62, 460–471 (2021).
Costa, C. et al. Cognitive decline risk stratification in people with late-onset epilepsy of unknown etiology: an electroencephalographic connectivity and graph theory pilot study. J. Alzheimers Dis. 88, 893–901 (2022).
Fernandes, M. et al. Cognitive functioning, cerebrospinal fluid Alzheimer’s disease biomarkers and cerebral glucose metabolism in late-onset epilepsy of unknown aetiology: a prospective study. Eur. J. Neurosci. 56, 5384–5396 (2022).
Article CAS PubMed Google Scholar
Hansson, O. Biomarkers for neurodegenerative diseases. Nat. Med. 27, 954–963 (2021).
Article CAS PubMed Google Scholar
Podcasy, J. L. & Epperson, C. N. Considering sex and gender in Alzheimer disease and other dementias. Dialogues Clin. Neurosci. 18, 437–446 (2016).
Article PubMed PubMed Central Google Scholar
Scheyer, O. et al. Female sex and Alzheimer’s risk: the menopause connection. J. Prev. Alzheimers Dis. 5, 225–230 (2018).
CAS PubMed PubMed Central Google Scholar
Zetterberg, H. & Blennow, K. Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics. Mol. Neurodegener. 16, 10 (2021).
Article CAS PubMed PubMed Central Google Scholar
Banote, R. K., Håkansson, S., Zetterberg, H. & Zelano, J. CSF biomarkers in patients with epilepsy in Alzheimer’s disease: a nation-wide study. Brain Commun. 4, fcac210 (2022).
Article PubMed PubMed Central Google Scholar
Johnson, E. L. et al. Association between midlife risk factors and late-onset epilepsy: results from the Atherosclerosis Risk in Communities study. JAMA Neurol. 75, 1375–1382 (2018).
Article PubMed PubMed Central Google Scholar
Stefanidou, M. et al. Bi-directional association between epilepsy and dementia: the Framingham Heart Study. Neurology 95, e3241–e3247 (2020).
Article CAS PubMed PubMed Central Google Scholar
Zhao, B. et al. Risk of seizures and subclinical epileptiform activity in patients with dementia: a systematic review and meta-analysis. Ageing Res. Rev. 72, 101478 (2021).
Dun, C. et al. Bi-directional associations of epilepsy with dementia and Alzheimer’s disease: a systematic review and meta-analysis of longitudinal studies. Age Ageing 51, afac010 (2022).
Beagle, A. J. et al. Relative incidence of seizures and myoclonus in Alzheimer’s disease, dementia with Lewy bodies, and frontotemporal dementia. J. Alzheimers Dis. 60, 211–223 (2017).
Article PubMed PubMed Central Google Scholar
DiFrancesco, J. C. et al. Adult-onset epilepsy in presymptomatic Alzheimer’s disease: a retrospective study. J. Alzheimers Dis. 60, 1267–1274 (2017).
Article CAS PubMed Google Scholar
Horvath, A. et al. Prevalence, semiology, and risk factors of epilepsy in Alzheimer’s disease: an ambulatory EEG study. J. Alzheimers Dis. 63, 1045–1054 (2018).
Lyou, H. J., Seo, K. D., Lee, J. E., Pak, H. Y. & Lee, J. H. Association of Alzheimer’s disease with the risk of developing epilepsy: a 10-year nationwide cohort study. Dement. Neurocogn. Disord. 17, 156–162 (2018).
Rauramaa, T. et al. Epilepsy in neuropathologically verified Alzheimer’s disease. Seizure 58, 9–12 (2018).
Baker, J., Libretto, T., Henley, W. & Zeman, A. The prevalence and clinical features of epileptic seizures in a memory clinic population. Seizure 71, 83–92 (2019).
Tabuas-Pereira, M. et al. Increased CSF tau is associated with a higher risk of seizures in patients with Alzheimer’s disease. Epilepsy Behav. 98, 207–209 (2019).
Arnaldi, D. et al. Epileps
留言 (0)